| pubmed-article:1717026 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1717026 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:1717026 | lifeskim:mentions | umls-concept:C0025663 | lld:lifeskim |
| pubmed-article:1717026 | lifeskim:mentions | umls-concept:C0079784 | lld:lifeskim |
| pubmed-article:1717026 | lifeskim:mentions | umls-concept:C0026473 | lld:lifeskim |
| pubmed-article:1717026 | lifeskim:mentions | umls-concept:C1533685 | lld:lifeskim |
| pubmed-article:1717026 | lifeskim:mentions | umls-concept:C0003241 | lld:lifeskim |
| pubmed-article:1717026 | lifeskim:mentions | umls-concept:C1524095 | lld:lifeskim |
| pubmed-article:1717026 | lifeskim:mentions | umls-concept:C0475208 | lld:lifeskim |
| pubmed-article:1717026 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:1717026 | pubmed:dateCreated | 1991-11-1 | lld:pubmed |
| pubmed-article:1717026 | pubmed:abstractText | We describe a rabbit intralymphnode immunization technique for obtaining a high titer antihuman CSF-1 antiserum with small amounts of antigen. This procedure provided a rapid (42 days after primo-injection), stable maximum immune response with a high titer antiserum precipitating 30% of 125I CSF-1 at a 1:25.000 dilution. The specificity of the immune serum was assessed by competitive binding experiments in RIA and neutralization of the CSF-1 biological activity in culture. The antiserum was also tested for its ability to detect CSF-1 in Western blotting, immunocytochemistry and immunohisto-chemistry. The results show that the immune serum specifically recognizes the biological active domain of human CSF-1 molecules from different origins and only detects dimeric forms. The potential uses of this anti CSF-1 antiserum are discussed. | lld:pubmed |
| pubmed-article:1717026 | pubmed:language | eng | lld:pubmed |
| pubmed-article:1717026 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1717026 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:1717026 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1717026 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1717026 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1717026 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1717026 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1717026 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1717026 | pubmed:issn | 1148-5493 | lld:pubmed |
| pubmed-article:1717026 | pubmed:author | pubmed-author:LanotteMM | lld:pubmed |
| pubmed-article:1717026 | pubmed:author | pubmed-author:MoreauAA | lld:pubmed |
| pubmed-article:1717026 | pubmed:author | pubmed-author:PraloranVV | lld:pubmed |
| pubmed-article:1717026 | pubmed:author | pubmed-author:Martin-Thouve... | lld:pubmed |
| pubmed-article:1717026 | pubmed:author | pubmed-author:BerradaLL | lld:pubmed |
| pubmed-article:1717026 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1717026 | pubmed:volume | 1 | lld:pubmed |
| pubmed-article:1717026 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1717026 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:1717026 | pubmed:pagination | 177-83 | lld:pubmed |
| pubmed-article:1717026 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:1717026 | pubmed:meshHeading | pubmed-meshheading:1717026-... | lld:pubmed |
| pubmed-article:1717026 | pubmed:meshHeading | pubmed-meshheading:1717026-... | lld:pubmed |
| pubmed-article:1717026 | pubmed:meshHeading | pubmed-meshheading:1717026-... | lld:pubmed |
| pubmed-article:1717026 | pubmed:meshHeading | pubmed-meshheading:1717026-... | lld:pubmed |
| pubmed-article:1717026 | pubmed:meshHeading | pubmed-meshheading:1717026-... | lld:pubmed |
| pubmed-article:1717026 | pubmed:meshHeading | pubmed-meshheading:1717026-... | lld:pubmed |
| pubmed-article:1717026 | pubmed:meshHeading | pubmed-meshheading:1717026-... | lld:pubmed |
| pubmed-article:1717026 | pubmed:meshHeading | pubmed-meshheading:1717026-... | lld:pubmed |
| pubmed-article:1717026 | pubmed:meshHeading | pubmed-meshheading:1717026-... | lld:pubmed |
| pubmed-article:1717026 | pubmed:meshHeading | pubmed-meshheading:1717026-... | lld:pubmed |
| pubmed-article:1717026 | pubmed:meshHeading | pubmed-meshheading:1717026-... | lld:pubmed |
| pubmed-article:1717026 | pubmed:meshHeading | pubmed-meshheading:1717026-... | lld:pubmed |
| pubmed-article:1717026 | pubmed:meshHeading | pubmed-meshheading:1717026-... | lld:pubmed |
| pubmed-article:1717026 | pubmed:meshHeading | pubmed-meshheading:1717026-... | lld:pubmed |
| pubmed-article:1717026 | pubmed:meshHeading | pubmed-meshheading:1717026-... | lld:pubmed |
| pubmed-article:1717026 | pubmed:meshHeading | pubmed-meshheading:1717026-... | lld:pubmed |
| pubmed-article:1717026 | pubmed:meshHeading | pubmed-meshheading:1717026-... | lld:pubmed |
| pubmed-article:1717026 | pubmed:meshHeading | pubmed-meshheading:1717026-... | lld:pubmed |
| pubmed-article:1717026 | pubmed:meshHeading | pubmed-meshheading:1717026-... | lld:pubmed |
| pubmed-article:1717026 | pubmed:meshHeading | pubmed-meshheading:1717026-... | lld:pubmed |
| pubmed-article:1717026 | pubmed:articleTitle | Intralymphnode injection of human monocyte macrophage colony stimulating factor (CSF-1) as a method of obtaining high titer anti-CSF-1 antibodies. | lld:pubmed |
| pubmed-article:1717026 | pubmed:affiliation | Laboratoire d'Hematologie, Centre Hospitalier Regional Universitaire, Nantes, France. | lld:pubmed |
| pubmed-article:1717026 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:1717026 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
